John Rundback, MD
@jrunmd
Advanced Interventional & Vascular Services LLP
NJ Endovascular & Amputation Prevention PC
ID: 1358332435
17-04-2013 01:56:40
598 Tweet
1,1K Followers
305 Following
Don’t miss this #OBL Spotlight on American Endovascular & Amputation Prevention in West Orange, NJ! "Our compassionate experience ... incredible patient experience, and commitment to patient care leads to extraordinary outcomes," says John Rundback, MD. okt.to/OjKBsa
We are honored that Kym McNicholas | Emmy Award-Winning Journalist from The Way To My Heart (lnkd.in/gPpgmFpG), Dr. Lorenzo Patrone, and Dr. George Vatakencherry visited our West Orange location to observe PAD cases led by Dr. John Rundback. John Rundback, MD GVATAKEN Lorenzo Patrone
Congratulations! Dr. Kevin Herman and the team at Holy Name Medical Center in Teaneck, NJ enrolled their first patient in the DEEPER REVEAL trial (NCT05358353), who was successfully treated for a lesion in the AT artery. Thanks to Dr. Herman Kevin Herman, PI John Rundback, MD, study
SIR members - email campaign Congress re inc Medicare rates. Pls sign if you feel so inclined? Cost of running a medical practice up by 47%, Medicare physician payments declined by 26% 2001 to 2023. -SIR Haven’t fact checked exact #’s but gist is real. TY Society of Interventional Radiology !!
Today on BackTable: John Rundback, MD returns to the show to discuss using MicroCT to evaluate the impact of endovascular treatments on PAD #medEd Sabeen Dhand Srini Tummala MD FSIR FSVM Eric Secemsky MD MSc Zola N'Dandu, MD Don Garbett Omar Solana MD NFT Sasha Ushinsky AngioDynamics, Inc. cms.megaphone.fm/channel/BTL269…
Raise the roof for DR MICHAEL R JAFF! I’m thrilled to share that our very own CMO has been named a recipient of the prestigious 2023 Pulse-Setter Awards presented by Cardiovascular Research Foundation. A well-deserved honor.
5/7 📌 CLI Treatment in Office-Based Labs: Deep Venous Arterialization in OBL Setting For critical limb ischemia, this treatment shows promise in wound healing and limb preservation, providing hope for "no-option" patients. doi.org/10.1016/j.jvir… John Rundback, MD